Completed PHASE3 INTERVENTIONAL 2-arm NCT01586208

Refractory Status Epilepticus Treatment Study

Refractory Status Epilepticus: Plasmatic Levels Monitorization Utility

Sponsor: Germans Trias i Pujol Hospital

Conditions Grand Mal Status Epilepticus Non-convulsive Status Epilepticus

Updated 5 times since 2017 Last updated: Mar 10, 2013 Started: Jan 31, 2010 Primary completion: May 31, 2012 Completion: Oct 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Grand Mal Status Epilepticus and Non-convulsive Status Epilepticus and is currently completed. Germans Trias i Pujol Hospital leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Germans Trias i Pujol Hospital
Hospital Clinic of Barcelona
Hospital Universitari de Bellvitge
Hospital Vall d'Hebron
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

Data source: Hospital Universitari de Bellvitge

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• L'Hospitalet de Llobregat, Spain